Literature DB >> 11561211

Distribution of 1,25-dihydroxyvitamin D3 receptor immunoreactivity in the limbic system of the rat.

T Walbert1, G F Jirikowski, K Prüfer.   

Abstract

We used immunocytochemistry to obtain a complete cellular and subcellular mapping of the 1,25-dihydroxyvitamin D3 receptor protein (VDR) in the rat limbic system. We observed specific VDR immunostaining in the nucleus as well as in the perinuclear cytoplasm of neuronal cells. The limbic system consists of a variety of neuronal structures, and is known to have influence on memory, behavior, emotions and reproduction. In the hippocampal formation, we found strong nuclear staining as well as less distinguished cytoplasmic VDR staining in CA1, CA3 and CA4. The CA2 area showed a unique cytoplasmic predominance of VDR. The amygdala was found to exhibit specific patterns of VDR distribution in the various regions of the nucleus. We observed distinct differences of VDR localization within the limbic preoptic areas of the hypothalamus. Further parts of the brain we analyzed included the mammillary bodies, the indusium griseum and the cingulate cortex. The subcellular distribution of VDR in regions of the limbic system suggests a specific functional role of the receptor protein and indicates a role for calcitriol as a neuroactive steroid.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11561211     DOI: 10.1055/s-2001-17210

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  17 in total

1.  Serum 25-hydroxyvitamin D and self-reported mental health status in adult Danes.

Authors:  L L N Husemoen; J F Ebstrup; E L Mortensen; P Schwarz; T Skaaby; B H Thuesen; T Jørgensen; A Linneberg
Journal:  Eur J Clin Nutr       Date:  2015-08-12       Impact factor: 4.016

Review 2.  Hypovitaminosis D in the elderly: from bone to brain.

Authors:  E P Cherniack; H Florez; B A Roos; B R Troen; S Levis
Journal:  J Nutr Health Aging       Date:  2008 Jun-Jul       Impact factor: 4.075

3.  Amyloid Beta 1-42 Alters the Expression of miRNAs in Cortical Neurons.

Authors:  Erdinç Dursun; Esin Candaş; Selma Yılmazer; Duygu Gezen-Ak
Journal:  J Mol Neurosci       Date:  2018-12-04       Impact factor: 3.444

4.  Vitamin D receptor and enzyme expression in dorsal root ganglia of adult female rats: modulation by ovarian hormones.

Authors:  Sarah E Tague; Peter G Smith
Journal:  J Chem Neuroanat       Date:  2010-10-20       Impact factor: 3.052

5.  Serum vitamin D concentrations are related to depression in young adult US population: the Third National Health and Nutrition Examination Survey.

Authors:  Vijay Ganji; Cristiana Milone; Mildred M Cody; Frances McCarty; Yong T Wang
Journal:  Int Arch Med       Date:  2010-11-11

Review 6.  Vitamin D as a potential therapy in amyotrophic lateral sclerosis.

Authors:  Alexandro Gianforcaro; Mazen J Hamadeh
Journal:  CNS Neurosci Ther       Date:  2014-02       Impact factor: 5.243

Review 7.  Combination treatment with progesterone and vitamin D hormone may be more effective than monotherapy for nervous system injury and disease.

Authors:  Milos Cekic; Iqbal Sayeed; Donald G Stein
Journal:  Front Neuroendocrinol       Date:  2009-04-24       Impact factor: 8.606

8.  Peripubertal vitamin D(3) deficiency delays puberty and disrupts the estrous cycle in adult female mice.

Authors:  Cary L Dicken; Davelene D Israel; Joe B Davis; Yan Sun; Jun Shu; John Hardin; Genevieve Neal-Perry
Journal:  Biol Reprod       Date:  2012-08-30       Impact factor: 4.285

9.  Cholecalciferol (vitamin D₃) improves myelination and recovery after nerve injury.

Authors:  Jean-Francois Chabas; Delphine Stephan; Tanguy Marqueste; Stephane Garcia; Marie-Noelle Lavaut; Catherine Nguyen; Regis Legre; Michel Khrestchatisky; Patrick Decherchi; Francois Feron
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

Review 10.  Vitamin D3 for the Treatment of Epilepsy: Basic Mechanisms, Animal Models, and Clinical Trials.

Authors:  Kevin Pendo; Christopher M DeGiorgio
Journal:  Front Neurol       Date:  2016-12-08       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.